Loading...

Cannabix Technologies Inc.

BLOZFPNK
Healthcare
Medical - Devices
$0.54
$0.001(0.17%)
U.S. Market opens in 4h 53m

Cannabix Technologies Inc. Fundamental Analysis

Cannabix Technologies Inc. (BLOZF) shows weak financial fundamentals with a PE ratio of -14.08, profit margin of -39.51%, and ROE of -3.03%. The company generates $0.0B in annual revenue with weak year-over-year growth of 0.00%.

Key Strengths

PEG Ratio-7.96
Current Ratio6.44

Areas of Concern

ROE-3.03%
Operating Margin-39.07%
Cash Position1.92%
We analyze BLOZF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -3236.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-3236.3/100

We analyze BLOZF's fundamental strength across five key dimensions:

Efficiency Score

Weak

BLOZF struggles to generate sufficient returns from assets.

ROA > 10%
-3.43%

Valuation Score

Excellent

BLOZF trades at attractive valuation levels.

PE < 25
-14.08
PEG Ratio < 2
-7.96

Growth Score

Weak

BLOZF faces weak or negative growth trends.

Revenue Growth > 5%
0.00%
EPS Growth > 10%
-48.54%

Financial Health Score

Excellent

BLOZF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.03
Current Ratio > 1
6.44

Profitability Score

Weak

BLOZF struggles to sustain strong margins.

ROE > 15%
-302.93%
Net Margin ≥ 15%
-39.51%
Positive Free Cash Flow
No

Key Financial Metrics

Is BLOZF Expensive or Cheap?

P/E Ratio

BLOZF trades at -14.08 times earnings. This suggests potential undervaluation.

-14.08

PEG Ratio

When adjusting for growth, BLOZF's PEG of -7.96 indicates potential undervaluation.

-7.96

Price to Book

The market values Cannabix Technologies Inc. at 56.11 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

56.11

EV/EBITDA

Enterprise value stands at -14.76 times EBITDA. This is generally considered low.

-14.76

How Well Does BLOZF Make Money?

Net Profit Margin

For every $100 in sales, Cannabix Technologies Inc. keeps $-39.51 as profit after all expenses.

-39.51%

Operating Margin

Core operations generate -39.07 in profit for every $100 in revenue, before interest and taxes.

-39.07%

ROE

Management delivers $-3.03 in profit for every $100 of shareholder equity.

-3.03%

ROA

Cannabix Technologies Inc. generates $-3.43 in profit for every $100 in assets, demonstrating efficient asset deployment.

-3.43%

Following the Money - Real Cash Generation

Operating Cash Flow

Cannabix Technologies Inc. generates limited operating cash flow of $-1.89M, signaling weaker underlying cash strength.

$-1.89M

Free Cash Flow

Cannabix Technologies Inc. generates weak or negative free cash flow of $-1.90M, restricting financial flexibility.

$-1.90M

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

BLOZF converts -2.04% of its market value into free cash.

-2.04%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-14.08

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-7.96

vs 25 benchmark

P/B Ratio

Price to book value ratio

56.11

vs 25 benchmark

P/S Ratio

Price to sales ratio

563.23

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.03

vs 25 benchmark

Current Ratio

Current assets to current liabilities

6.44

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-3.03

vs 25 benchmark

ROA

Return on assets percentage

-3.43

vs 25 benchmark

ROCE

Return on capital employed

-3.94

vs 25 benchmark

How BLOZF Stacks Against Its Sector Peers

MetricBLOZF ValueSector AveragePerformance
P/E Ratio-14.0829.43 Better (Cheaper)
ROE-302.93%692.00% Weak
Net Margin-3950.65%-44295.00% (disorted) Weak
Debt/Equity0.030.35 Strong (Low Leverage)
Current Ratio6.444.48 Strong Liquidity
ROA-342.56%-18045.00% (disorted) Weak

BLOZF outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Cannabix Technologies Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

38.91%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

11.95%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ